Press Releases

08/4/2020

Two Studies Presented at AACR Meeting Deepen Understanding Of Cancer Mechanisms

Researchers Use Menarini’s Liquid Biopsy Technology to Find Genetic Alterations in Cancer Cells that May Improve Prognosis and Treatment

continue →

Topics: CELLSEARCH, metastatic breast cancer, Multiple myeloma, HER2, AACR

07/13/2020

Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

Strategic partnership will focus on commercializing CELLSEARCH platform for
COVID-19 related use cases, along with other COVID-19 related products

continue →

Topics: CELLSEARCH, COVID-19, OpGEN

06/11/2020

Menarini Silicon Biosystems Begins Distribution of Rapid COVID-19 Antibody Test in North America

The test detects antibodies made by the immune system in response to infection by the novel coronavirus in as little as 10 minutes

continue →

Topics: COVID-19, Coronavirus, COVID-19 Ab test, SARS-CoV-2, diagnostic

06/10/2020

New ASCO Studies Offer Evidence for Use of Circulating Tumor Cells as a Prognostic Biomarker for Advanced Prostate and Breast Cancer

Results from prospective trials show a "clear prognostic value" for CTC counts

continue →

Topics: CTCs, CELLSEARCH, metastatic breast cancer, prostate cancer, ASCO

04/27/2020

Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19

Enumeration of Circulating Endothelial Cells (CECs) with CELLSEARCH platform may offer a new tool for investigating the role of the damaged endothelium in SARS-CoV-2 infection and clinical manifestation.

continue →

Topics: CELLSEARCH, COVID-19, CECs, Coronavirus, Circulating Endothelial Cells

02/28/2020

Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy

Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, rare cells

12/10/2019

New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

Northwestern University researchers use gold standard  liquid-biopsy technology to deepen understanding of metastatic breast cancer

continue →

Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells

10/31/2019

Menarini Silicon Biosystems to Debut VRNxT Technology at 25th Annual Meeting of the Association for Molecular Pathology

Automated volume reduction instrument increases precision and accuracy in rare cell workflows

continue →

Topics: Liquid biopsy, Precision Medicine, rare cells, volume reduction, VRNxT

09/23/2019

Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer

continue →

Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells

09/19/2019

Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee

Cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows

continue →